Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Atox, Biogen, Diamedica, Editas, Eisai, Entera, Hoth, Lantheus, Neoleukin, Oblato, Scynexis, SOBI, Ultragenyx, X4.